)
Edge11 Sep 2026
Texas Pacific Land Corporation: Keeper of the Permian Basin
Land once granted to a failed 19th-century railroad now generates royalties for Texas Pacific Land Corporation across the Permian Basin.
FluoGuide
FluoGuide (FLOU) investor relations material
FluoGuide Investing in Life Science 2026 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Investing in Life Science 2026 summary22 Sep, 2026
Market opportunity and technology
Cancer recurrence after surgery is a major problem, addressed by a drug that lights up cancer during surgery.
The solution targets uPAR, an enzyme highly expressed in aggressive cancers, enabling visualization.
Market potential is significant, with 45 million cancer procedures projected in 2030.
Clinical validation and regulatory progress
Clinical trials have been conducted, and FDA granted Fast Track designation for high-grade glioma.
Partnerships with major med tech companies are in place to facilitate market penetration.
The drug is administered pre-surgery, binds to cancer, and enables real-time visualization during operations.
Focus areas and clinical endpoints
Focus is on brain tumors (especially high-grade glioma) and head and neck cancers.
The technology helps surgeons distinguish cancer from normal tissue, reducing unnecessary removal.
Primary clinical endpoint is removal of contrast-enhancing tumor; secondary endpoint is removal of infiltrative cancer.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from FluoGuide
- FDA Fast Track and pivotal U.S. trial site activation drive clinical and financial progress.FLOU
Q2 2026 - FDA Fast Track and IND approval drive clinical progress and cash runway through Q1 2027.FLOUQ1 2026
- Regulatory progress, capital raise, and positive clinical data support future growth.FLOUQ4 2025
- FG001 enables precise cancer surgery, backed by strong data, partnerships, and secured funding.FLOUSEB Nordic Seminar presentation
- Regulatory clarity, strong financing, and clinical progress position FG001 for approval.FLOUQ3 2025
- Innovative imaging agent lights up cancer for surgeons, targeting broad markets with strong FDA support.FLOUInvesting in Life Science 2025
- Clinical milestones and strategic partnerships advance FG001, despite ongoing net losses.FLOUQ2 2025
- FG001 advances toward approval with positive clinical data and improved financials.FLOUQ3 2024
- SEK 60M capital raise extends FluoGuide's runway as FG001 advances toward late-stage trials.FLOUQ2 2024
Next FluoGuide earnings date
Q3 202626 Nov, 2026
FluoGuide
Next FluoGuide earnings date
Q3 202626 Nov, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage